PANI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 9.574
EU - Europa 2.465
AS - Asia 847
SA - Sud America 27
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 12.956
Nazione #
US - Stati Uniti d'America 9.539
GB - Regno Unito 736
IT - Italia 583
HK - Hong Kong 421
SE - Svezia 414
BG - Bulgaria 195
CN - Cina 178
DE - Germania 114
FI - Finlandia 81
IE - Irlanda 69
TR - Turchia 56
FR - Francia 34
MY - Malesia 31
IN - India 27
CA - Canada 25
ES - Italia 25
JP - Giappone 24
LT - Lituania 24
UA - Ucraina 23
CH - Svizzera 21
NL - Olanda 19
SG - Singapore 19
VN - Vietnam 17
KH - Cambogia 16
TW - Taiwan 16
BE - Belgio 15
AT - Austria 14
BR - Brasile 12
KR - Corea 12
EU - Europa 11
AU - Australia 10
ZA - Sudafrica 10
HU - Ungheria 9
RO - Romania 9
RS - Serbia 9
CZ - Repubblica Ceca 8
HR - Croazia 7
IL - Israele 7
AR - Argentina 6
GR - Grecia 6
PL - Polonia 6
LU - Lussemburgo 5
NO - Norvegia 5
PH - Filippine 5
CO - Colombia 4
DK - Danimarca 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
EE - Estonia 3
EG - Egitto 3
ID - Indonesia 3
IR - Iran 3
MD - Moldavia 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
RU - Federazione Russa 3
AL - Albania 2
CR - Costa Rica 2
DZ - Algeria 2
LK - Sri Lanka 2
ME - Montenegro 2
MX - Messico 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BT - Bhutan 1
EC - Ecuador 1
GH - Ghana 1
GT - Guatemala 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MA - Marocco 1
MC - Monaco 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 12.956
Città #
Fairfield 1.775
Chandler 1.099
Woodbridge 793
Ashburn 741
Houston 666
Seattle 598
Wilmington 578
Cambridge 539
Southend 450
Hong Kong 419
Nyköping 356
Ann Arbor 241
Princeton 220
San Diego 210
Sofia 195
New York 154
Modena 143
Beijing 97
London 96
Helsinki 74
Dublin 69
Dearborn 49
Izmir 41
Rome 41
Eugene 39
Edinburgh 35
Milan 33
Norwalk 33
Kilburn 21
Redwood City 19
Chicago 18
San Jose 18
Stockholm 17
Hounslow 15
Jacksonville 15
Parma 15
Shanghai 15
Dong Ket 14
Prescot 14
Vienna 14
Bologna 13
Brussels 13
Madrid 13
Tokyo 13
Paris 12
Southwark 12
Amsterdam 11
Chiswick 11
Frankfurt am Main 11
Liebefeld 9
Atlanta 8
Belgrade 8
Brentwood 8
Budapest 8
Catania 8
Grafing 8
Montreal 8
Reggio Emilia 8
Taipei 8
Bremen 7
Los Angeles 7
Pontedera 7
Toronto 7
Zagreb 7
Dallas 6
Milwaukee 6
Palermo 6
Prague 6
Acton 5
Bari 5
Istanbul 5
Kuala Lumpur 5
Lappeenranta 5
Naples 5
Priverno 5
São Bernardo do Campo 5
São Paulo 5
Wuhan 5
Zurich 5
Boardman 4
Bucharest 4
Carpi 4
Cesena 4
Chennai 4
Copenhagen 4
Florence 4
Fremont 4
Hyderabad 4
Luxembourg 4
Miami 4
Napoli 4
New Orleans 4
Oslo 4
Ottawa 4
Padova 4
San Mateo 4
Sydney 4
Taichung 4
Vicenza 4
Vilnius 4
Totale 10.367
Nome #
Stamina therapies: Let the record stand 189
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 188
Nutraceuticals: opening the debate for a regulatory framework 187
Association of neovascular age-related macular degeneration with month and season of birth in Italy 163
Adherence to selective serotonin and serotonin-norepinephrine reuptake inhibitor prescriptions affects overall medication adherence in older persons: Evidence from the Italian nationwide osmed health-db database 162
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 153
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 147
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 142
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 140
Take This Cognitive Training Efficacy Bar Fight Outside (to a Regulatory Agency) 135
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 134
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways 130
A case-control study of visually evoked postural responses in childhood with primary headaches 130
Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy 129
Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans 125
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice 115
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research 113
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 113
Steps forward in regulatory pathways for acute and chronic heart failure 112
Safety and Efficacy of Red Yeast Rice Phytocomplex and Lovastatin: a Comparative Analysis 109
The endless frontier? The recent increase of R&D productivity in pharmaceuticals 109
Approaches to attenuated psychosis syndrome treatments: A perspective on the regulatory issues 100
Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice 96
Balancing access to medicines and sustainability in Europe: An analysis from the network of competent authorities on pricing and reimbursement (CAPR) 95
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats 95
Digital Phenotyping and Dynamic Monitoring of Adolescents Treated for Cancer to Guide Intervention: Embracing a New Era 95
In vitro evidence for the presence of [ 3H]-haloperidol uptake in rat brain 91
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 90
Identification and validation of biomarkers for autism spectrum disorders 88
Antinociceptive activity of Δ9-tetrahydrocannabinol non-ionic microemulsions 85
Impact of reimbursement limits on patient access to direct-acting antivirals in Italy: Analysis of data from national registries 84
Scaling up health knowledge at European level requires sharing integrated data: An approach for collection of database specification 83
Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression 83
Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic 82
Generic and biosilimilar medicines use and expenditure: A report from the National Observatory on the Use of Medicines (OsMed) of the Italian Medicines Agency (AIFA) 81
Use and reimbursement of off-label drugs in pediatric anesthesia: The Italian experience 80
Practical issues with amisulpride in the management of patients with schizophrenia 79
Sleep deprivation in the rat: an animal model of mania 79
Clinical trials and late-stage drug development for Alzheimer's disease: An appraisal from 1984 to 2014 79
Immunocytochemical study of the forebrain serotonergic innervation in Sardinian alcohol-preferring rats 78
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis 78
Kounis Syndrome: An analysis of spontaneous reports from international pharmacovigilance database 77
Disclosure of grounds of European withdrawn and refused applications: A step forward on regulatory transparency 77
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2′, 4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7] cyclohepta[1,2-c]pyrazole-3-carboxamide 77
Monitoring registries at Italian medicines agency: Fostering access, guaranteeing sustainability 76
Regulatory evaluation of Glybera in Europe-two committees, one mission 76
Validated method to determine quetiapine and norquetiapine in microsomal matrix by LC MS-MS: Implication in quetiapine metabolism 76
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry 76
Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration 76
Environmental enrichment influences mouse hippocampal neuroinflammatory response 75
Effectiveness and cost effectiveness of bevacizumab in metastatic colorectal cancer 75
High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA) 75
Kounis syndrome due to antibiotics: A global overview from pharmacovigilance databases 74
The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex 74
ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action 74
Circulating levels of anticonvulsant metabolites of progesterone in women with partial epilepsy in the intercritical phase 74
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency 73
Managed entry agreements 73
Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia 73
Clinical implications of dopamine research in schizophrenia 73
DSM-5 and clinical trials in psychiatry: Challenges to come? 73
Synthesis and in vitro evaluation of trifluoroethylamine analogues of enkephalins 72
Is HCMV vaccine an unmet need? The state of art of vaccine development 72
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 72
Haloperidol, but not clozapine, produces dramatic catalepsy in Δ 9-THC-treated rats: Possible clinical implications 71
Evolutionary psychopharmacology, mental disorders, and ethical behavior 71
Tricyclic pyrazoles. Part 5. novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 ligands using molecular hybridization based on scaffold hopping 70
Consensus on the use of substituted benzamides in psychiatric patients 70
Contrasting effects of diazepam and repeated restraint stress on latent inhibition in mice 70
The future is now: Model-based clinical trial design for Alzheimer's disease 69
Novel epigenetic target therapy for prostate cancer: A preclinical study 68
Rare diseases and effective treatments: Are we delivering? 65
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 65
Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: Implications for the antiglaucoma properties of marihuana 65
Transparency in medical research: Time for a paradigm shift 65
Alternative pricing strategies for cancer drugs 65
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 65
The European Medicines Agency's strategies to meet the challenges of Alzheimer disease 64
Insights Into the Decision Making of Advisory Groups to the Italian Medicines Agency 64
Biosimilars: The paradox of sharing the same pharmacological action without full chemical identity 64
Transparency in medical research: Time for a paradigm shift 62
Building a virtual archive using brain architecture and Web 3D to deliver neuropsychopharmacology content over the Internet 62
Subthreshold depression in older subjects: An unmet therapeutic need 62
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 62
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 61
The placebo arm in clinical studies for treatment of Psychiatric Disorders: A Regulatory Dilemma 61
Are we ready? What is missing and what is needed? A regulator's perspective 61
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 61
(-)S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors 60
The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex 60
Reflections on decisions made on the well-established use of medicinal products by EU regulators and the ECJ 60
Nimodipine inhibits cocaine-induced dopamine release and motor stimulation 60
Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients 60
Are "social drugs" (tobacco, coffee and chocolate) related to the bipolar spectrum? 60
The effects of novel and newly approved antipsychotics on serum prolactin levels: A comprehensive review 59
Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent 59
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors 57
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease 57
Brain dialysis provides evidence for D2-dopamine receptors modulating noradrenaline release in the rat frontal cortex 57
The role of limbic and cortical regions in schizophrenia: Focus on dopamine 57
Totale 8.628
Categoria #
all - tutte 89.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019194 0 0 0 0 0 0 0 0 0 0 77 117
2019/2020698 24 19 7 35 40 87 140 60 59 51 147 29
2020/20214.699 116 54 87 1.617 709 339 103 537 84 573 213 267
2021/20222.849 132 283 70 98 70 180 162 105 369 345 730 305
2022/20233.065 321 160 162 245 320 446 44 479 449 54 303 82
2023/20241.650 128 146 121 197 383 136 79 264 77 59 60 0
Totale 13.235